Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-01T01:43:01.334Z Has data issue: false hasContentIssue false

Chapter 9 - Detection of Genetic Syndromes

Published online by Cambridge University Press:  04 November 2017

By
Mai P. Hoang
Edited by
Mai P. Hoang
Mai P. Hoang
Affiliation:
Harvard Medical School, Boston
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Immunohistochemistry in Diagnostic Dermatopathology , pp. 212 - 223
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Moreira, L, Balaguer, F, Lindor, N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308(15):1555–65.Google Scholar
Lachiewicz, AM, Wilkinson, TM, Groben, P, Ollila, DW, Thomas, NE. Muir-Torre syndrome. Am J Clin Dermatol 2007;8(5):315–19.Google Scholar
Ponti, G, Losi, L, Di Gregorio, C, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: Role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005;103(5):1018–25.CrossRefGoogle ScholarPubMed
Cohen, PR, Kohn, SR, Kurzrock, R. Association of sebaceous gland tumors and internal malignancy: The Muir-Torre syndrome. Am J Med 1991;90(5):606–13.Google Scholar
Abbott, JJ, Hernandez-Rios, P, Amirkhan, RH, Hoang, MP. Cystic sebaceous neoplasms in Muir-Torre syndrome. Arch Pathol Lab Med 2013;127(5):614–17.Google Scholar
Rutten, A, Burgdorf, W, Hugel, H, et al. Cystic sebaceous tumors a marker lesions for the Muir-Torre syndrome: A histopathologic and molecular genetic study. Am J Dermatopathol 1999;21(5):405–13.Google Scholar
Al-Shobaili, HA, Al-Ghamdi, KM, Al-Ghamdi, WA. Cystic sebaceous carcinoma: Is it a constant pathognomic marker for Muir-Torre syndrome? J Drugs Dermatol 2007;6(5):540–43.Google ScholarPubMed
Schwartz, RA, Torre, DP. The Muir-Torre syndrome: A 25-year retrospect. J Am Acad Dermatol 1995;33(1):90–104.Google Scholar
Kruse, R, Ruzicka, T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med 2004;10(3):136–41.Google Scholar
Toon, CW, Walsh, MD, Chou, A, et al. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. Am J Surg Pathol 2013;37(10):1592–602.CrossRefGoogle ScholarPubMed
Kalloger, SE, Allo, G, Mulligan, AM, et al. Use of mismatch repair immunohistochemistry and microsatellite instability testing: Exploring Canadian practices. Am J Surg Pathol 2012;36(4):560–69.CrossRefGoogle ScholarPubMed
Shia, J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. J Mol Diagn 2008;10(4):293–300.Google Scholar
Cornejo, KM, Hutchinson, L, Deng, A, et al. BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis. Hum Pathol 2014;45(6):1213–20.CrossRefGoogle ScholarPubMed
Musulén, E, Sanz, C, Muñoz-Mármol, AM, Aurelio Ariza, A. Mismatch repair protein immunohistochemistry: A useful population screening strategy for Lynch syndrome. Hum Pathol 2014;45(7):1388–96.CrossRefGoogle ScholarPubMed
Jessup, CJ, Redston, M, Tilton, E, Reimann, JD. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Hum Pathol 2016;49(3):1–9.Google Scholar
Everett, JN, Raymond, VM, Dandapani, M, Marvin, M, Kohlmann, W, et al. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol 2014;150(12):1315–21.Google Scholar
Ponti, G, Ponz de Leon, M, Maffei, S, et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 2005;68(5):442–47.Google Scholar
O’Shea, AM, Cleary, SP, Croitoru, MA, et al. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology 2008;53(2):184–94.Google Scholar
Singh, RS, Grayson, W, Redston, M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol 2008;32(6):936–42.Google Scholar
Abdel-Rahman, MH, Pilarski, R, Cebulla, CM, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011;48(12):856–59.Google Scholar
Carbone, M, Ferris, LK, Baumann, F, et al. BAP1 cancer syndrome: Malignant mesotheliomas, uveal and cutaneous melanoma, and MBAITs. J Transl Med 2012;10:179. doi: 10.1186/1479-5876-10-179.Google Scholar
Wadt, K, Choi, J, Chung, JY, et al. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res 2012;25(6):815–18.Google Scholar
Wiesner, T, Obenauf, AC, Murali, R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011;43(10):1018–21.CrossRefGoogle ScholarPubMed
Popova, T, Hebert, L, Jacquemin, V, et al. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 2013;92(6):974–80.CrossRefGoogle ScholarPubMed
Busam, KJ, Sung, J, Wiesner, T, et al. BRAFV600E-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes. Am J Surg Pathol 2013;37(2):193–99.CrossRefGoogle Scholar
de la Fouchardiere, A, Cabaret, O, Savin, L, et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 2015;88(3):273–77.Google Scholar
Mochel, MC, Piris, A, Nose, V, Hoang, MP. Loss of BAP1 expression in basal cell carcinomas in patients with germline BAP1 mutations. Am J Clin Pathol 2015;143(6):901–4.Google Scholar
Piris, A, Mihm, MC Jr, Hoang, MP. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Hum Pathol 2015;46(2):239–45.CrossRefGoogle ScholarPubMed
Pena-Llopis, S, Vega-Rubin-de-Celis, S, Liao, A, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2011;44(7):1018–21.Google Scholar
Ladanyi, M, Zauderer, MG, Krug, LM, et al. New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res 2012;18(17):4485–90.CrossRefGoogle ScholarPubMed
Barletta, JA, Bellizzi, AM, Hornick, JL. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol 2011;35(10):1505–11.Google Scholar
Nelen, MR, Padberg, GW, Peeters, EA, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996;13(1):114–16.Google Scholar
Jin, M, Hampel, H, Pilarski, R, et al. Phosphatase and tensin homolog immunohistochemical staining and clinical criteria for Cowden syndrome in patients with trichilemmoma or associated lesions. Am J Dermatopathol 2013;35(6):637–40.Google Scholar
Shon, W, Wolz, MM, Sukov, WR, et al. Phosphatase and tensin homologue status in sporadic and Cowden syndrome-associated trichilemmomas: Evaluation of immunohistochemistry and fluorescence in situ hybridization. Br J Dermatol 2014;170(5):1201–4.Google Scholar
Zabetian, S, Mehregan, D. Cowden syndrome: Report of two cases with immunohistochemical analysis for PTEN expression. Am J Dermatopathol 2012;34(6):632–34.Google Scholar
Peiro, G, Adrover, E, Guijarro, J, et al. Synchronous bilateral breast carcinoma in a patient with Cowden syndrome: A case report with morphologic, immunohistochemical and genetic analysis. Breast J 2010;16(1):77–81.CrossRefGoogle Scholar
Al-Zaid, T, Ditelberg, JS, Prieto, VG, et al. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 2012;39(5):493–99.CrossRefGoogle ScholarPubMed
Reed, WB, Walker, R, Horowitz, R. Cutaneous leiomyomata with uterine leiomyomata. Acta Dermatologica Venerologica 1973;53(5):406–16.Google Scholar
Tomlinson, IP, Alam, NA, Rowan, AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30(4):406–10.Google Scholar
Bayley, JP, Launonen, V, Tomlinson, IP. The fumarate hydratase mutation database: An online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 2008;9:20.Google Scholar
Chan, I, Wong, T, Martinez-Mir, A, Christiano, AM, McGrath, JA. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Clin Exp Dermatol 2005;30(1):75–78.Google Scholar
Merino, MJ, Torres-Cabala, C, Pinto, P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 2007;31(10):1578–85.CrossRefGoogle ScholarPubMed
Sanz-Ortega, J, Vocke, C, Stratton, P, Linehan, WM, Merino, MJ. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol 2013;37(1):74–80.Google Scholar
Llamas-Velasco, M, Requena, L, Kutzner, H, et al. Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. J Cutan Pathol 2014;41(11):859–65.Google Scholar
Jin, M, Hampel, H, Zhou, X, et al. BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome. Am J Clin Pathol 2013;140(2):177–83.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×